Michael Derby

Michael L.
Derby was the founder of Norphan Pharmaceuticals, Inc. (founded in 2011) where he served as the Chief Executive Officer from 2011 to 2013.
He is also the founder of TardiMed Sciences LLC (founded in 2019) where he currently holds the position of Managing Partner.
In addition, he is the founder of Castle Creek Biosciences, Inc. (founded in 2015) where he currently serves as the Vice Chairman.
Furthermore, he was the founder of PaxMedica, Inc. (founded in 2018) where he was the Executive Chairman from 2018 to 2023.
Mr. Derby's current job(s) include being the Executive Chairman at Timber Pharmaceuticals LLC and Visiox Pharma LLC.
His former job(s) include being the Executive Chairman at Timber Pharmaceuticals, Inc. from 2019 to 2021.
He also held positions as an Independent Director at Acasti Pharma, Inc., a Principal at Merck & Co., Inc., a Principal at EGS Healthcare Capital Partners LLC from 2002 to 2008, an Equity Research Associate at ING Baring Furman Selz LLC, and a Vice President-Corporate Development at Marathon Pharmaceuticals LLC.
Mr. Derby's education history includes a graduate degree from the University of Rochester in 1997, an undergraduate degree from The Johns Hopkins University in 1995, and an MBA from The Leonard N Stern School of Business.